These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7234006)

  • 21. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
    Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
    P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitetanus and antidiphtheria immunity in newborns.
    Durbacă S
    Roum Arch Microbiol Immunol; 1999; 58(3-4):267-72. PubMed ID: 11845464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of tetanus immunity in the Kocaeli Region, Turkey.
    Dundar V; Yumuk Z; Ozturk-Dundar D; Erdoğan S; Gacar G
    Jpn J Infect Dis; 2005 Oct; 58(5):279-82. PubMed ID: 16249621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rates of cellular and antibody incorporation of 3H-histidine in mice during secondary responses to tetanus toxoid.
    Stucki M; Hess MW; Cottier H; Hankes LV; Stoner RD
    J Reticuloendothel Soc; 1974 Jun; 15(6):453-65. PubMed ID: 4854033
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
    Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunising against tetanus - a continuing problem.
    Dastur FD; D'Sa JA; Badami PV; Awatramani VP; Dixit SK
    J Postgrad Med; 1980 Jan; 26(1):22-7. PubMed ID: 7373561
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cellular immune response and glomerulonephritis--their detection with the Tetamun intracutaneous test].
    Kettritz R; Schöntube M; Göbel U; Natusch R
    Z Urol Nephrol; 1988 Oct; 81(10):647-55. PubMed ID: 3266404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Duration of tetanus immunity in relation to the number of doses of vaccine].
    Ribero ML; Fara GM; Del Corno G
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):464-75. PubMed ID: 7248075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetanus immunization--an additional note.
    Med Lett Drugs Ther; 1973 Jul; 15(15):64. PubMed ID: 4712987
    [No Abstract]   [Full Text] [Related]  

  • 30. [An evaluation of the efficacy of the accelerated immunization method in guinea pigs immunized with tetanus toxoid].
    Rybicka I; Albrycht H; Wysokińska T
    Med Dosw Mikrobiol; 1970; 22(2):153-9. PubMed ID: 5428965
    [No Abstract]   [Full Text] [Related]  

  • 31. [Intracutaneous test using diphtheria-tetanus toxoid for study of cellular immunity].
    John M; Rumler W
    Dtsch Med Wochenschr; 1978 Jul; 103(29):1182-3. PubMed ID: 668556
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serological study carried out in Cambodia during a tetanus vaccination in adults].
    Schlumberger M; Yvonnet B; Que HV; Chhem DB; Saliou P; Le Tu TC; Glaziou P
    Bull Soc Pathol Exot; 2008 Feb; 101(1):36-42. PubMed ID: 18432006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
    CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Objective verification of tetanus immune status in an apparently non-immune population.
    Murphy NM; Olney DB; Brakenbury PH
    Br J Clin Pract; 1994; 48(1):8-9. PubMed ID: 8179993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of tetanus immunity.
    Pieroni RE; Coplin TW; Leeper JD
    J Med Assoc State Ala; 1981 Jul; 51(1):38-40. PubMed ID: 7338690
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetanus in an immunized, healthy adult.
    Heydari AA; Sarveghad MR
    J Emerg Med; 2006 Oct; 31(3):305. PubMed ID: 16982368
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunity to tetanus among the 25 to 30-year-old population].
    Simonsen O; Kjeldsen K; Møller-Madsen B; Nørgaard A; Simonsen L; Heron I
    Ugeskr Laeger; 1984 Apr; 146(18):1341-4. PubMed ID: 6495408
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current trends in the use of combined serum and vaccine in tetanus prevention].
    Olivo R; Fabio U
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):455-63. PubMed ID: 7248074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of the phenomenon of rosette formation and the leukocytic formula in blood donors immunized with the antigens of the RH-HR blood group system].
    Klimova KN; Danilova TN
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):12-5. PubMed ID: 417339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.